The $1.5 Trillion Weight Loss Economy of 2030: A Breakdown of the Market Reshaping Health By 2030, the global weight loss industry is projected to exceed $1.5 trillion, fueled by rising obesity rates, tech innovation, and a cultural shift toward personalized health. From AI-driven wearables to CRISPR gene editing, here’s how this booming market will transform … Read more
The fight against obesity is entering an exciting new era. With blockbuster drugs like Wegovy (semaglutide) and Zepbound (tirzepatide) already transforming weight management, pharmaceutical giants are racing to develop next-generation therapies. The pipeline includes oral alternatives, multi-targeted injectables, and novel mechanisms that could redefine obesity treatment. Here’s a breakdown of the most anticipated drugs—and when … Read more
Key Highlights: A New Hope for Obesity and Diabetes Obesity and type 2 diabetes (T2D) are global health crises, affecting 1 billion and 537 million adults worldwide, respectively . Orforglipron, an oral GLP-1 receptor agonist developed by Eli Lilly, offers a groundbreaking solution. Unlike injectable alternatives, this pill-based medication simplifies treatment, making it more accessible and user-friendly. This blog … Read more
